BLOOM43 Wearable Device Debuts in U.S. to Reduce Breast Surgery Complications
Plexāā has launched its BLOOM43 platform in the U.S., a wearable and app designed to improve surgical outcomes for breast surgery patients through preconditioning.
Plexāā has launched its BLOOM43 platform in the U.S., a wearable and app designed to improve surgical outcomes for breast surgery patients through preconditioning.
A new fat-based injectable is reshaping non-surgical body contouring. Plastic Surgery Practice examines the science and clinical adoption of alloClae with Tiger Aesthetics President Caroline Van Hove and Dr David Shafer.
The partnership aims to provide peer-to-peer expertise and support for aesthetic providers adopting the recently approved Evolysse hyaluronic acid filler line.
Compatible with Alma Pixel and Alma Hybrid systems, the treatment is designed to provide a gentler approach to laser skin renewal.
rater8, a healthtech company specializing in reputation management, has launched raVE to help medical practices maintain visibility and credibility in AI-driven patient search results.